Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
Recruiting
Observational Study
Stroke, Ischemic
Transient Ischemic Attack
Coagulation Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 360 (estimated)
- Sponsor
- Cwm Taf University Health Board (NHS) · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Annually 100,000 strokes occur, placing stroke as the largest cause of disability in the UK. 90% of strokes are preventable, leading to national focus on programmes including "The National Stroke Programme" to act on preventing, treating, and improving post-stroke care. Importantly, over 25% of ischaemic stroke sufferers have previously had a Transient Ischaemic Attack (TIA), which presents the bi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
The inclusion criteria for phase 1 (initial patient recruitment) will be:
1. Patients with or without diagnosis of TIA made by a physician working in stroke medicine, sufficiently so to start post-TIA care or so that no further investigation is thought necessary to confirm or refute the diagnosis.
…
Contacts